Diogo Silva

6PUBLICATIONS
46CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedTumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 28, 2026
Correction: Cruz et al. Drug Development in Non-Oncogene-Addicted Non-Small Cell Lung Cancer. Cancers 2026, 18, 880.

|Apr 27, 2026
Phase I Trial of Ipatasertib plus Atezolizumab Enhances PI3K/AKT Pathway Immune Responses in Solid Tumors and Refractory Glioblastoma.

|Mar 14, 2026
Drug Development in Non-Oncogene-Addicted Non-Small Cell Lung Cancer.

Pedro Cruz, Cristina Boixareu, Diogo J Silva

|Sep 02, 2024
Decentralized Clinical Trials in Early Drug Development-A Framework Proposal.

Diogo J Silva, Blessie Elizabeth Nelson, Jordi Rodon

|Jul 05, 2022
Evolving Evidence for the Optimization of Neoadjuvant Therapy in Triple-Negative Breast Cancer.

Diogo Silva, Alexandra Mesquita

|Oct 08, 2021
Rectal mixed adenoneuroendocrine carcinoma: Case report.

Diogo J Silva, Joana Dos Santos, Ana Paula Vaz

Pageof 1

Frequent Collaborators

3 joint publications

Anna Minchom

2 joint publications

Pedro Cruz

2 joint publications

Cristina Boixareu

2 joint publications

Joshua Ting